Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Harkin, Hatch Reload In Hunt For Full DSHEA Funding, Implementation

This article was originally published in The Tan Sheet

Executive Summary

The supplement industry's staunchest allies in the Senate, Tom Harkin and Orrin Hatch, introduce a bill aimed at fully funding dietary supplement regulation and timed to deflect criticism of the industry from a committee hearing
Advertisement

Related Content

FDA Oversteps Supplement Authority With NDI Notification Guidance – Hatch
Hatch Faces Possible Primary Contest With Chaffetz
Dietary Supplement Caucus Goes Bicameral, Adds Hatch, Harkin As Co-Chairs
FDA Will Enforce NDI Notification Requirement Without Warning
Sen. Hatch Offers Strategies For Thwarting Growing DSHEA Threats
Rep. Chaffetz Aims To Bring Together "Fractured" Supplement Industry
Senate Supplement Hearing Spotlights Self-Regulation, FDA Enforcement
Senate Supplement Hearing Spotlights Self-Regulation, FDA Enforcement
Legislation Seeks Space For Supplements On Health Care Reform Slate
Dietary Supplement Safety Issues Maintain Momentum On Capitol Hill

Topics

Advertisement
UsernamePublicRestriction

Register

PS104155

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel